CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published ahead of print on July 6, 2006
Clin J Am Soc Nephrol 1: 1029-1038, 2006
© 2006 American Society of Nephrology
doi: 10.2215/CJN.00790306
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.00790306v1
1/5/1029    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gallon, L. G.
Right arrow Articles by Kaufman, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallon, L. G.
Right arrow Articles by Kaufman, D. B.

Transplantation

Effect of Prednisone versus No Prednisone as Part of Maintenance Immunosuppression on Long-Term Renal Transplant Function

Lorenzo G. Gallon*, Johan Winoto*, Joseph R. Leventhal{dagger}, Michele A. Parker{ddagger}, and Dixon B. Kaufman{dagger}

* Department of Medicine, Division of Nephrology, and {dagger} Department of Surgery, Division of Solid Organ Transplantation, Northwestern University, Chicago, Illinois; and {ddagger} Duke Cardiovascular Center, Duke University Medical School, Durham, North Carolina

Address correspondence to: Dr. Lorenzo Gallon, 675 N. St. Clair, Galter-Pavilion 17-200, Chicago, IL 60611. Phone: 312-695-4457; Fax: 312-695-9194; E-mail: l-gallon{at}northwestern.edu

Corticosteroids have been a component of maintenance immunosuppression for renal transplant since the 1960s and have helped to reduce the rate of acute rejection. Corticosteroids, however, have many adverse effects, and with the development of new immunosuppressive medications, many transplant centers have adopted protocols that eliminate or completely avoid the use of corticosteroids. Despite promising short-term results, the impact of corticosteroid elimination on long-term kidney function still is unclear. This single-center, retrospective, sequential study analyzed 212 renal transplant patients with a median follow-up of 5 yr. All patients received induction with IL-2 receptor antagonist and maintenance immunosuppression with mycophenolate mofetil and tacrolimus. Ninety-six patients were maintained on chronic prednisone, and 116 were maintained without chronic prednisone (rapid steroid elimination). Kaplan-Meier patient and graft survival at 7 yr after transplantation were not statistically different between the two groups. Rate and severity of acute cellular rejection were similar. Furthermore, the slope of GFR decline per month at 5 yr after transplantation was not statistically different between the two groups. Prednisone-treated patients had a significantly higher incidence of hyperlipidemia and posttransplantation diabetes when compared with patients with rapid steroid elimination. It was concluded that with the current immunosuppressive medications, the use of chronic prednisone to maintain long-term kidney function and prevent acute cellular rejection is not justified.




This article has been cited by other articles:


Home page
 CJASNHome page
A. C. Shirali and M. J. Bia
Management of Cardiovascular Disease in Renal Transplant Recipients
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Nephrology.